Covidien has released its contrast delivery system with radiofrequency identification (RFID) technology in the U.S.
The system combines its unit-dose, RFID-enabled Ultraject prefilled contrast media syringes with the company's RFID-enabled OptiVantage DH power injector, according to the Hamilton, Bermuda-based firm.
Related Reading
Covidien debuts Optistar Elite injector, July 17, 2008
Covidien names R&D team, July 2, 2008
Covidien acquires handheld injector technology, May 14, 2008
FDA clears Covidien RFID contrast system, May 8, 2008
Covidien posts strong Q2, May 7, 2008
Copyright © 2008 AuntMinnie.com